|
|
|
|
| LEADER |
01636nam a2200313 u 4500 |
| 001 |
EB001840005 |
| 003 |
EBX01000000000000001003994 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
180702 r ||| eng |
| 245 |
0 |
0 |
|a Long-term use of ondansetron, dolasetron, and granisetron for the prevention of nausea and vomiting
|h Elektronische Ressource
|b a review of the clinical effectiveness and safety
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2014, 23 April 2014
|
| 300 |
|
|
|a 1 PDF file (7 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Nausea / prevention & control
|
| 653 |
|
|
|a Canada
|
| 653 |
|
|
|a Ondansetron / therapeutic use
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Indoles / therapeutic use
|
| 653 |
|
|
|a Granisetron / therapeutic use
|
| 653 |
|
|
|a Vomiting / prevention & control
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
| 500 |
|
|
|a Title from PDF caption title. - "CADTH Rapid Response Service."
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK269203
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a The purpose of this review is to provide evidence on the comparative clinical effectiveness and safety of the long-term use (> 5 days) of serotonin receptor antagonists (5-HT3RAs) for the prevention of nausea and vomiting
|